Serial #88373385
LIVE

Serial Number

88373385

Owner

PAIGE.AI, Inc.

Attorney

Mark Leonardo

First Use Date

Feb 21, 2019

Filing Date

Apr 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88373385 Trademark

Serial Number: 88373385 • Registration: 6389841

Serial #88373385 is a trademark filed by PAIGE.AI, Inc. on April 5, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PAIGE.AI, Inc. (12 trademarks)

New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

April 5, 2019

Registration Date

June 15, 2021

First Use Anywhere

February 21, 2019

First Use in Commerce

February 21, 2019

Published for Opposition

July 9, 2019

Goods & Services

Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2026 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2026 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 15, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 14, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 13, 2021 CNPR
EXAMINER'S AMENDMENT ENTERED
May 13, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 13, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
May 13, 2021 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
May 13, 2021 SNEA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 29, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 29, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 29, 2021 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 29, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 29, 2020 GNFR
SU - FINAL REFUSAL - WRITTEN
Oct 29, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2020 CRFA
ASSIGNED TO LIE
Oct 6, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 11, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 13, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 13, 2020 AITU
USE AMENDMENT FILED
Aug 3, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 3, 2020 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 8, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 8, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 8, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 8, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2020 EXRA
SOU EXTENSION 1 GRANTED
Mar 3, 2020 EX1G
SOU EXTENSION 1 FILED
Mar 3, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 3, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2019 NOAM
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 14, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 14, 2019 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2019 NONP
ASSIGNED TO LIE
May 30, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2019 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 8, 2019 GPRN
PRIORITY ACTION E-MAILED
May 8, 2019 GPRA
PRIORITY ACTION WRITTEN
May 8, 2019 CPRA
ASSIGNED TO EXAMINER
May 1, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 25, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2019 NWOS
NEW APPLICATION ENTERED
Apr 9, 2019 NWAP